BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 31 filers reported holding BIOLIFE SOLUTIONS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,901,000 | +16.7% | 122,855 | -15.4% | 0.61% | +1.2% |
| Q3 2020 | $4,200,000 | +83.0% | 145,135 | +3.4% | 0.60% | +59.8% |
| Q2 2020 | $2,295,000 | +71.3% | 140,369 | -0.5% | 0.38% | +38.7% |
| Q1 2020 | $1,340,000 | -60.9% | 141,053 | -33.4% | 0.27% | -35.6% |
| Q4 2019 | $3,427,000 | +2.1% | 211,782 | +4.9% | 0.42% | -13.0% |
| Q3 2019 | $3,356,000 | -11.8% | 201,839 | -10.1% | 0.48% | -7.3% |
| Q2 2019 | $3,807,000 | -29.5% | 224,623 | -25.5% | 0.52% | -34.5% |
| Q1 2019 | $5,397,000 | -27.2% | 301,682 | -51.1% | 0.80% | +36.9% |
| Q4 2018 | $7,414,000 | +53.8% | 616,370 | +123.8% | 0.58% | +2.8% |
| Q3 2018 | $4,819,000 | +42.8% | 275,397 | -6.9% | 0.57% | +34.1% |
| Q2 2018 | $3,374,000 | +187.9% | 295,728 | +29.4% | 0.42% | +174.0% |
| Q1 2018 | $1,172,000 | -23.1% | 228,546 | -10.1% | 0.15% | -23.4% |
| Q4 2017 | $1,525,000 | +215.1% | 254,096 | +199.8% | 0.20% | +204.5% |
| Q3 2017 | $484,000 | – | 84,755 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |